Enrico Celestino Nista

Università Cattolica del Sacro Cuore

Papers

1

Total Citations

49

H-Index

1

About

Enrico Celestino Nista is a leading figure in gastroenterology and hepatology, with a research focus sharpened on the molecular mechanisms and clinical management of pancreatic diseases, particularly pancreatic cancer. His work addresses the critical challenge of early diagnosis and treatment in a malignancy notorious for its late detection and poor prognosis. In his highly cited 2023 review, "State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine," Nista synthesizes the latest advances in the field, highlighting the urgent need for novel biomarkers and targeted therapies to move beyond conventional care. This paper, with 49 citations, underscores his role in bridging the gap between bench research and clinical application. Beyond pancreatic cancer, his contributions span the study of chronic pancreatitis, gastrointestinal bleeding, and the gut microbiome’s role in systemic disease. Nista’s work consistently emphasizes precision medicine, aiming to tailor treatments to individual patient profiles. His research not only illuminates the pathophysiological underpinnings of these complex conditions but also directly informs evolving clinical guidelines, making him a vital voice in the fight against one of oncology’s most formidable foes.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
49 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Università Cattolica del Sacro Cuore

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago